EPZ-719 |
EPZ-719 : Inhibitor of SETD2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SETD2 |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
EPZ-719 displayed a >8000-fold selectivity in a panel of 14 histone methyltransferases (DOT1L >200 µ ...
Potency Cellular
In Vitro
SETD2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acsmedchemlett.1c00272
In Vivo Validations
Mouse
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
3.1 h
Systemic clearance:
53.3 mL/min/kg
Area Under the Curve::
314 h*ng/mL
Volume of Distribution at Steady-State:
8.15 L/Kg
DOI Reference: 10.1021/acsmedchemlett.1c00272
Dose: 30 mg/Kg
Route of delivery:
Oral
Plasma half life:
0.2 h
Cmax:
667 ng/mL
Tmax:
1.6 h
Area Under the Curve::
803 h*ng/mL
Bioavailability:
70%
DOI Reference: 10.1021/acsmedchemlett.1c00272
Dose: 100 mg/Kg
Route of delivery:
Oral
Plasma half life:
2.1 h
Systemic clearance:
87 mL/min/Kg
Cmax:
3993 ng/mL
Tmax:
1.2 hr
Area Under the Curve::
19900 h*ng/mL
Bioavailability:
100%
DOI Reference: 10.1021/acsmedchemlett.1c00272
Chemical Information
| Molecular Formula | C22H31FN4O3S |
| SMILEs | Cc1ccc(F)c2cc(C(=O)N[C@@H]3CCC[C@H](N4CC[C@H](N(C)S(C)(=O)=O)C4)C3)[nH]c12 |
| InChI | InChI=1S/C22H31FN4O3S/c1-14-7-8-19(23)18-12-20(25-21(14)18)22(28)24-15-5-4-6-16(11-15)27-10-9-17(13-27)26(2)31(3,29)30/h7-8,12,15-17,25H,4-6,9-11,13H2,1-3H3,(H,24,28)/t15-,16+,17+/m1/s1 |
| Molecular weight | 450.21 Da |
| AlogP | 0.0 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 62 |